Future Trends in the Clinical Nutrition Market and What to Expect in the Coming Years

Market Overview:

The market for clinical nutrition is growing steadily primarily because there is an ever-increasing global demand for nutritional therapies to treat a host of medical conditions, especially among the old. The rise in chronic diseases of the nature of diabetes and cancer, whose managements require specialized nutritional means, has therefore become a strong driving force in the market. As tailored nutritional products have recently found better development and with many health promotions and awareness of clinical nutrition, the market is expected to rise more during the forecast period.

Study Assumption Years:

• Base Year: 2024
• Historical Year: 2019-2024
• Forecast Year: 2025-2033

Clinical Nutrition Market Key Takeaways:

• The clinical nutrition market was valued at USD 55.8 billion in 2024 and is projected to reach USD 104.6 billion by 2033, growing at a CAGR of 7.2%.
• The increasing prevalence of chronic conditions like malnutrition, cancer, and digestive disorders is driving demand.
• The demand for enteral and parenteral nutrition is growing, particularly in hospitals and home healthcare settings.
• Asia-Pacific is expected to witness the fastest growth due to improving healthcare access and rising disposable incomes.
• Increased focus on personalized nutrition is shaping new product offerings in the market.
• Growing awareness about the benefits of clinical nutrition for overall health and recovery fuels the demand for nutritional interventions.

Market Growth Factors:

Increase in Chronic Diseases and Medical Conditions:

Chronic diseases are becoming more common these days, and such diseases include diabetes, cancer, and cardiovascular diseases. Such conditions lead to complications that enhance the need for specialized nutrition aimed at nurturing the better management and recovery of the patient. Malnutrition is common with these diseases, and this greatly enhances the requirement for clinical nutrition. Nutritional therapy will be at greater demand for relief from symptoms and for recovery and health benevolence. Therefore, much more patients requiring nutritional support should see an increase in other forms of nutrition like enteral and parenteral nutrition during the forecast.

Technological Advancements in Nutrition Products:

Technological advancement in clinical nutrition products, including innovations in nutrient delivery systems, has improved the efficacy of nutritional interventions. The result is that there are more sophisticated, targeted nutrition solutions: personalized or tailored nutrition products can bring better results. Nutritional solutions are now being designed for specific patient requirements, for example, renal or liver disease a factor in the explosive uptake of clinical applications. Clinical nutrition products that interweave biotechnology with nutraceuticals have broadened the product spectrum and enhanced the nutritional quality and suitability of myriad conditions.

Growing Healthcare Awareness and Improved Access:

On the other hand, the growing awareness regarding the significance of nutrition in health management and recovery has been another factor favoring growth. As more people recognize nutrition's role in the prevention and management of diseases, a laudable growth in demand for clinical nutrition products emerges. This phenomenon is in full swing especially in developed areas, where infrastructure for health-care services along with education into nutrition is much more advanced. In emerging markets, healthcare is now being improved in terms of accessibility, in turn favoring demand creation for clinical nutrition, especially for malnutrition and related disorders. These increasingly preventive health-care-related factors and issues will continue to fortify the market.

Request a sample copy of the report: https://www.imarcgroup.com/clinical-nutrition-market/requestsample

Market Segmentation:

• By Product Type:

o Enteral Nutrition: Nutrition delivered directly into the digestive tract, either through oral supplements or feeding tubes, is commonly used in patients who cannot consume food orally.
o Parenteral Nutrition: Administered intravenously, this product type is used for patients who cannot digest food through the gastrointestinal tract, providing essential nutrients directly into the bloodstream.

• By Application:

o Cancer: Patients undergoing cancer treatment often experience weight loss and malnutrition, making clinical nutrition crucial for recovery and maintaining body weight.
o Diabetes: Clinical nutrition plays a role in managing blood sugar levels, supporting the dietary needs of diabetic patients for better glucose control.
o Malnutrition: Clinical nutrition is essential for patients suffering from malnutrition, particularly in the elderly and those recovering from surgery or illness.
o Gastrointestinal Diseases: Nutritional support is important for patients with digestive system disorders, aiding recovery and improving gastrointestinal function.
o Others: Includes applications in conditions such as renal failure, respiratory diseases, and neurological disorders, where specialized nutrition is required.

• By End-User:

o Hospitals & Clinics: Hospitals are the largest end-users of clinical nutrition products due to the high demand for enteral and parenteral feeding in patients with critical illnesses.
o Home Care Settings: An increasing number of patients are receiving clinical nutrition at home, especially those with chronic diseases or recovering from surgeries.
o Ambulatory Care Centers: These facilities offer clinical nutrition to patients in outpatient settings, especially for conditions requiring ongoing nutritional support.

• By Region:

o North America (United States, Canada)
o Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
o Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
o Latin America (Brazil, Mexico, Others)
o Middle East and Africa

Regional Insights:

The Asia-Pacific region is emerging as a dominant force in the global clinical nutrition market due to rapid urbanization, improving healthcare infrastructure, and increasing awareness about the importance of nutritional care. The demand for clinical nutrition products is on the rise in the region, given the presence of a large population coupled with rising incomes and increasing incidence of chronic diseases. Countries like China, India, and Japan are in the forefront, joined by their governments in tackling malnutrition and improving healthcare access. Alongside, the geriatric population and rise in adoption of advanced nutritional solutions in this region act as other important growth engines. Asia-Pacific will be the fastest-growing market during the forecast period, acting as an ecosystem for clinical nutrition innovation and development.

Recent Developments & News:

Recent trends in the clinical nutrition market indicate a growing inclination towards personalized nutrition. Companies focus on tailor-made nutrition products designed for individual health requirements, especially for persons with specific chronic conditions like cancer, diabetes, and cardiovascular diseases. Delivery systems are also being improved, such as feeding tubes and IV solutions, in a manner that increases comfort and outcomes for the patient. The use of technology in product development remains a paramount driver for the growth of the market.

Key Players:

Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc, Reckitt Benckiser Group PLC, etc.

Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=5995&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.